Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation

Transplantation Proceedings

Volumn 30, Issue 8, 1998, Pages 4082-4084

  Baker, G M ^a   Martin, Jill E ^a   Jang, R ^a   Schroeder, T J ^a   Armitstead, J A ^a   Myre, S ^a   First, M R ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CADAVER DONOR; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE CLASSIFICATION; DRUG COST; GRAFT REJECTION; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT CODING; PRIORITY JOURNAL; TREATMENT PLANNING;

AZATHIOPRINE; CADAVER; COSTS AND COST ANALYSIS; GRAFT REJECTION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; OHIO; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS;

EID: 0032435422     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01349-9     Document Type: Conference Paper

References (8)

1. 1. Keown P, Hayry P, Mathew T, et al: Transplantation 61:1029, 1996
2. 2. Sollinger HW for the US Renal Transplant Mycophenolate Mofetil Study Group: Transplantation 60:225, 1995
3. 3. Danovitch G, Deierhoi M, Ferguson R, et al: Transplantation 61:722, 1996
4. 4. Danovitch GM: Kidney Int 48(Suppl 52):S-93, 1995
5. 5. Gonwa TA: Clin Transplant 10:128, 1996
6. 6. Pichlmayer R for the European Mycophenolate Mofetil Cooperative Study Group: Lancet 345:1321, 1995
7. 7. Sullivan SD, Garrison LP, Best JH, and members of the US Renal Transplant Mycophenolate Mofetil Study Group: J Am Soc Nephrol 8:1592, 1997
8. th Annual Meeting, Chicago, Illinois, May, 1997